GENE ONLINE|News &
Opinion
Blog

Autoimmune Disease
With New Funding, ACELYRIN Licenses First Therapeutic and Leaps into Late-Stage Trials for Autoimmune Diseases
2021-11-17
Mozart Therapeutics Makes Play with $55 Million Series A to Capitalize on Novel Tregs Pathway
2021-10-27
GentiBio Bags $157 Million in Series A to Fund Development of Treg Cell Therapies
2021-08-11
COVID-19: FDA Adds New Warning For a Rare Autoimmune Disorder to J&J’s Vaccine
2021-07-14
Janssen’s Multiple Sclerosis Drug Snags FDA Win after Besting Sanofi’s Blockbuster in Phase 3
2021-03-21
Merck Acts on its Post-Keytruda Plan, Spends $1.85B to Acquire Pandion for Autoimmune Therapies
2021-02-26
Johnson & Johnson to Acquire Momenta Pharmaceutical Inc. for $6.5 Billion
2020-08-20
The Modern Authority in Genetics: Exclusive Interview with Dr. Yusuke Nakamura
2017-10-13
LATEST
Biotech Showcase 2022: Healing the Psyche with Psychedelia
2022-01-17
Sex Dimorphism in Obesity and the Impact of Estrogen Hormone Therapy on Cardiometabolic Health
2022-01-17
ARM 2022: Industry Briefs on Cell and Gene Therapies
2022-01-17
Study Reveals a Form of Four-Stranded DNA that Links Protein Deficiency and Premature Aging
2022-01-17
Shanghai’s Everest Medicines Licenses Covid-19 Oral Antivirals from Singapore’s National Drug Discovery Platform
2022-01-17
Digital Health Programme to Connect British and Taiwanese Leaders
2022-01-17
Pfizer: Pneumonia Shot Can Be Given with COVID-19 Vaccine in Older Adults
2022-01-16
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!